Table 1 Patient Demographics of the Study Cohort.
From: Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
Non-CRPC | CRPC | |||
|---|---|---|---|---|
BPH | Newly diagnosed PC | PC-ADT | ||
Number of patients | 287 | 289 | 57 | 60 |
Median age (years, IQR) | 68 (62–74) | 78 (74–83) | 78 (74–81) | 76 (70–79) |
Median initial PSA (ng/mL, IQR) | 6.4 (4.9–9.0) | 8.6 (5.8–14) | 17 (13–38) | 101 (21–513) |
PSA at N-glycan analysis (ng/mL, IQR) | 0.04 (0.01–0.24) | 50 (6.9–272) | ||
